# Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck

> **NCT01737008** · PHASE1 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 12 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** dacomitinib
- **RADIATION:** Radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01737008
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737008, "Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01737008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*